In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.

scientific article published on 22 June 2011

In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10717544.2011.589088
P698PubMed publication ID21696294
P5875ResearchGate publication ID51241340

P50authorSimon Anthony YoungQ47801834
Ilva D. RupenthalQ54195935
Ying-Shan ChenQ114291015
Raid Ghassan AlanyQ37840315
Colin GreenQ37840331
P2860cites workOligonucleotide analogues as potential chemotherapeutic agentsQ39573965
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.Q40095319
Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion methodQ40308524
Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cellsQ40618965
Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryQ40713744
Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epitheliumQ40824854
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?Q40834751
Preparation of microspheres by the solvent evaporation techniqueQ43706872
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.Q44062476
Critical determinants in PLGA/PLA nanoparticle-mediated gene expressionQ44403133
Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticlesQ44589782
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distributionQ45233463
Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiencyQ46675585
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.Q47883515
Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes.Q47912118
Antisense down regulation of connexin31.1 reduces apoptosis and increases thickness of human and animal corneal epitheliaQ48030663
Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino estersQ49113556
Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles.Q50941498
Expression of gap junction proteins Cx26, Cx31.1, Cx37, and Cx43 in developing and mature rat epidermisQ28583153
Nonviral gene therapy: promises and challengesQ33840998
The delivery of antisense therapeuticsQ34062621
Novel non-endocytic delivery of antisense oligonucleotidesQ34062631
Regulation of phagocytosis and endo-phagosomal trafficking pathways in Dictyostelium discoideumQ34189270
Modeling and comparison of dissolution profilesQ34215811
Chemical modification of gene silencing oligonucleotides for drug discovery and developmentQ36101387
Innovative nanotechnologies for the delivery of oligonucleotides and siRNA.Q36585342
State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.Q37213383
Molecular mechanisms of antisense drugs: RNase H.Q38337536
Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cellsQ38549934
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)493-501
P577publication date2011-06-22
P1433published inDrug DeliveryQ5308838
P1476titleIn vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
P478volume18

Reverse relations

cites work (P2860)
Q38765826Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells.
Q58764302Folate and Borneol Modified Bifunctional Nanoparticles for Enhanced Oral Absorption
Q64030465Förster Resonance Energy Transfer-Based Stability Assessment of PLGA Nanoparticles in Vitro and in Vivo
Q50239899Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits
Q38119238Nanoparticles in the ocular drug delivery

Search more.